Drug intelligence / Profile preview

Gengnian Anshen capsules

Development stage: Unknown
Lead developer: Hunan Anbang Pharmaceutical
Administration: Oral

Overview

Gengnian Anshen capsules is a traditional Chinese medicine (TCM) formulation developed by Changsha Dingbang Medical Technology and Anbang Pharmaceutical for the treatment of menopausal syndrome (specifically with a traditional Chinese medicine pattern of kidney yin-yang deficiency). It is a multi-herb botanical mixture designed to regulate endocrine and autonomic nervous system functions, alleviate menopausal symptoms, and improve sleep quality. A Phase III clinical trial (CTR20132960) evaluating its efficacy and safety in women aged 40 to 55 years has been completed in China, although its overall development has since been terminated.

Other names: Gengnian Anshen Capsule更年安神胶囊

Beyond the preview

Go deeper on Gengnian Anshen capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gengnian Anshen capsules.

Explore the full profile